Announcement PDF Market Announcement 28 March 2024 Resonance Health Limited (ASX: RHT) – Trading Halt Description The securities of Resonance Health Limited (‘RHT’) will be placed in trading halt at the request of RHT, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 3 April 2024 or when the announcement is released to the market. Issued by ASX Compliance 28 March 2024 ASX Limited #10710193v1 Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au ASX Release 28 March 2024 Mr Damian Dinelli Senior Adviser, Listings Compliance ASX Limited Level 40, Central Park 152-158 St Georges Terrace PERTH WA 6000 Australia By email: Damian.Dinelli@asx.com.au tradinghaltsperth@asx.com.au Dear Damian Request for Trading Halt: Resonance Health Ltd (ASX: RHT) (Company) We request a trading halt to be applied to our ordinary securities pursuant to ASX Listing Rule 17.1 and set out below details of the request: 1. We would like the trading halt to commence immediately. 2. The trading halt is necessary to assist the Company in managing its continuous disclosure obligations as the Company expects to make a market sensitive announcement in relation to a material acquisition (Announcement). 3. The trading halt is to last until the earlier of the commencement of normal trading on 3 April 2024 or when the Company releases the Announcement. We are not aware of any reason why the trading halt should not be granted or of any other information necessary to inform the market about the trading halt. Please contact me if you require any further information. Yours sincerely Mitchell Wells Non-executive Director & Company Secretary Resonance Health Ltd Resonance Health Ltd ABN: 96 006 762 492 141 Burswood Road, Burswood, WA 6100, AUSTRALIA Postal: PO Box 71, Burswood, WA 6100, AUSTRALIA www.resonancehealth.com T + 61 8 9286 5300 info@resonancehealth.com